The search for new tuberculosis drug targets under traditional laboratory methods has historically proven to be arduous and ...
Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug ...
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) and rare paediatric disease designation ...
The company has already kicked off an open-label Phase I trial of ABX1100 in Canada following positive results from a study of healthy volunteers.
Zacks.com on MSN2h
RARE Reports New Upbeat Data From Sanfilippo Syndrome Drug StudyUltragenyx Pharmaceutical RARE reported new findings from an ongoing, pivotal study of its investigational candidate, UX111 (ABO-102) AAV gene therapy, for Sanfilippo syndrome type A (MPS IIIA). Per ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
US Patent US 12,109,192 B covers the two preferred crystalline forms of S-pindolol benzoate. Actimed Therapeutics is a clinical stage speciality pharmaceutical company focused on bringing innovation ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a ...
A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a ...
A groundbreaking cannabinoid-based antimicrobial, Silvanex, fights drug-resistant infections with a synergy of silver, CBC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback